Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway

Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH. Although silibinin is used for the treatment of NASH in clinical, its effect on CFLAR-JNK pathway in NASH remains unclear. This study aimed to investigate the effect of sil...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yayun, Xu, Wei, Zhai, Ting, You, Jiaojiao, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664044/
https://www.ncbi.nlm.nih.gov/pubmed/31384535
http://dx.doi.org/10.1016/j.apsb.2019.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664044/
https://www.ncbi.nlm.nih.gov/pubmed/31384535
http://dx.doi.org/10.1016/j.apsb.2019.02.006

Ejemplares similares